NasdaqGM - Nasdaq Real Time Price USD
Lantheus Holdings, Inc. (LNTH)
Tune into earnings calls Now streaming directly on quote pages.
80.49
-24.35
(-23.23%)
At close: May 7 at 4:00:02 PM EDT
82.00
+1.51
+(1.88%)
Pre-Market: 6:11:03 AM EDT
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 6 | 6 | 6 | 13 |
| Avg. Estimate | 1.67 | 1.74 | 6.68 | 7.85 |
| Low Estimate | 1.63 | 1.66 | 6.6 | 7.06 |
| High Estimate | 1.69 | 1.9 | 6.76 | 9.3 |
| Year Ago EPS | 1.8 | 1.7 | 6.76 | 6.68 |
Revenue Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 12 | 12 | 13 | 13 |
| Avg. Estimate | 392.62M | 397.24M | 1.58B | 1.75B |
| Low Estimate | 381M | 385.2M | 1.55B | 1.6B |
| High Estimate | 407.2M | 417.55M | 1.62B | 1.97B |
| Year Ago Sales | 394.09M | 378.73M | 1.53B | 1.58B |
| Sales Growth (year/est) | -0.37% | 4.89% | 3.08% | 10.48% |
Earnings History
| Currency in USD | 6/30/2024 | 9/30/2024 | 12/31/2024 | 3/31/2025 |
|---|---|---|---|---|
| EPS Est. | 1.83 | 1.56 | 1.54 | 1.65 |
| EPS Actual | 1.8 | 1.7 | 1.59 | 1.53 |
| Difference | -0.03 | 0.14 | 0.05 | -0.12 |
| Surprise % | -1.64% | 9.10% | 3.04% | -7.49% |
EPS Trend
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 1.67 | 1.74 | 6.68 | 7.85 |
| 7 Days Ago | 1.73 | 1.78 | 7.02 | 8.01 |
| 30 Days Ago | 1.74 | 1.79 | 7.02 | 8.02 |
| 60 Days Ago | 1.74 | 1.8 | 6.99 | 7.99 |
| 90 Days Ago | 1.64 | 1.69 | 7 | 7.7 |
EPS Revisions
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | 1 | -- | -- | 1 |
| Up Last 30 Days | -- | -- | 2 | 2 |
| Down Last 7 Days | -- | 1 | 1 | -- |
| Down Last 30 Days | 2 | 2 | 1 | 1 |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| LNTH | -7.41% | 2.16% | -1.23% | 17.55% |
| S&P 500 | 12.50% | 3.24% | 7.95% | 13.84% |
Upgrades & Downgrades
| Maintains | B. Riley Securities: Buy to Buy | 3/21/2025 |
| Maintains | Truist Securities: Buy to Buy | 2/27/2025 |
| Reiterates | JMP Securities: Market Outperform to Market Outperform | 1/14/2025 |
| Initiated | Goldman Sachs: Buy | 12/18/2024 |
| Reiterates | Truist Securities: Buy to Buy | 11/8/2024 |
| Maintains | JMP Securities: Market Outperform to Market Outperform | 11/7/2024 |
Related Tickers
RGC Regencell Bioscience Holdings Limited
189.99
+25.82%
NBIX Neurocrine Biosciences, Inc.
121.61
+2.26%
BCRX BioCryst Pharmaceuticals, Inc.
10.08
-1.85%
ELAN Elanco Animal Health Incorporated
12.01
+26.29%
ZTS Zoetis Inc.
155.99
+4.08%
TEVA Teva Pharmaceutical Industries Limited
17.60
+9.18%
UTHR United Therapeutics Corporation
306.92
+4.03%
SXTC China SXT Pharmaceuticals, Inc.
1.9000
-7.32%
HROW Harrow, Inc.
24.59
+1.95%
ALKS Alkermes plc
30.38
+0.07%